News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
News Conference News ESC 2024 ‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS Michael O'Riordan September 09, 2024
News Daily News DES Best for In-Stent Restenosis, but DCBs Also Viable Michael O'Riordan August 13, 2024
News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT Michael O'Riordan May 28, 2024
News Conference News ACC 2024 PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE L.A. McKeown April 08, 2024
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Conference News TCT 2021 More DAPT Duration Data, More Calls to Tailor to Individual Patients Shelley Wood November 05, 2021
News Daily News DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry Caitlin E. Cox September 15, 2021
News Conference News ESC 2021 MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk Shelley Wood August 28, 2021
News Conference News ‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III Shelley Wood November 19, 2020
News Conference News TCT 2020 Stent Polymer Face-off Calls Bioresorbable Coatings Into Question Shelley Wood October 17, 2020
News Conference News CRT 2020 Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback Michael O'Riordan February 28, 2020
News Conference News CRT 2020 BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis L.A. McKeown February 25, 2020
News Daily News Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis Michael O'Riordan February 10, 2020
News Conference News LINC 2020 COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose L.A. McKeown January 28, 2020
News Conference News VIVA 2019 Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee? L.A. McKeown November 06, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
News Daily News More Acute Stent Thrombosis With Synergy Stent in Bern PCI Registry Michael O'Riordan August 14, 2019